SYSCHEM (INDIA) LTD.
Latest filings
- Trading window closed for Q2 FY27 results period · Compliance
- Syschem India publishes 33rd AGM notice in newspapers · Compliance
- Syschem 33rd AGM on Sep 30: auditor change, RPTs, director pay · Board & Shareholder Meetings
- Annual Report and 33rd AGM notice filed; key resolutions include auditor change and RPTs · Board & Shareholder Meetings
- Syschem publishes 33rd AGM notice in newspapers · Compliance
- Additional details on Statutory Auditor STAV and Co. resignation to BSE · Management Changes
- Clarification on proposed statutory auditor fee · Management Changes
- AGM notice, director reshuffle, auditor change approved · Board & Shareholder Meetings
- Syschem board swaps top director roles, auditor exits citing certificate expiry · Management Changes
- Board outcome: AGM notice, director reshuffle, new statutory auditor · Board & Shareholder Meetings
- Statutory Auditor STAV & Co resigns due to expired peer review certificate · Management Changes
- Clarification on typo in Investor Presentation - Q2 should read Q1 · Compliance
- Syschem India Q2 FY26-27 results: Revenue moderates, PBT turns negative · Investor Communications
- Syschem publishes Q1 FY27 unaudited results in newspapers · Compliance
- Clarification on lapse of 31.97 lakh convertible warrants · Fund Raising
- Q1 FY27 loss at Rs 1.67 cr; convertible warrants lapse, Rs 3.92 cr forfeited · Results
- SYSCHEM Q1 FY26 swings to Rs 1.67 cr loss; warrants lapse and forfeit · Results
- Warrants lapse and Q1 results - Syschem posts loss of Rs. 1.67 crore · Fund Raising
- Board meeting on 04 Aug 2026 to consider Q1 FY27 results · Results
- Syschem Files Q1 FY27 Share Capital Reconciliation Report with BSE · Compliance
- Board notes shareholders rejected re-designation and pay proposals for two directors · Management Changes
- Postal Ballot: Both Director Re-designation Resolutions Rejected · Board & Shareholder Meetings
- Shareholders reject director re-designation resolutions in postal ballot · Board & Shareholder Meetings
- Syschem promoters acquire 8.12 percent stake via preferential issue · Ownership Changes
- Special Window for Re-lodgement of Share Transfer Requests · Compliance
- RTA certificate submitted under SEBI Regulation 74(5) for Q1 FY27 · Compliance
- Syschem India: 43.5 lakh warrants converted into equity shares at Rs 49 · Fund Raising
- Promoters convert warrants into 43.52 lakh equity shares · Fund Raising
- Promoter Ranjan Jain sells 34,730 shares via open market · Ownership Changes
- Promoter Ruchika Jain sells 20,000 shares via open market · Ownership Changes
- Promoter Ranjan Jain sells 15,000 shares via open market · Ownership Changes
- Promoter Ranjan Jain sells 50,000 shares via open market · Ownership Changes
- Allotment of 2,50,000 equity shares under ESOP Scheme 2024 · Capital Market Events
- Allotment of 2,50,000 equity shares under ESOP Scheme 2024 · Capital Market Events
- Promoter Ranjan Jain sells 80,270 shares via open market · Ownership Changes
- Trading window closed for quarter ended June 2026 · Compliance
- Announcement under regulation 30(LODR): Updating in regards to earlier disclosure made dated 15-04-2026, regarding Fraudulent Transfer of funds and receive of recovery order. · Regulatory & Legal
- Shareholders Meeting/Postal Ballot: Newspaper Advertisement · Compliance
- 1st Notice of Postal Ballot for the FY 2026-27. · Board & Shareholder Meetings
- Update on earlier disclosure dated 26.02.2024 for filling a case before NCLT by Financial creditor of the company, company entered into Settlement agreement. · Regulatory & Legal
- 1st Postal Ballot for the Financial Year 2026-27: Newspaper Advertisements. · Compliance
- Pursuant to regulation 30: Change in Designation of Directors due to change in role and responsibility. · Management Changes
- Outcome of Board Meeting dated 03.06.2026 · Management Changes
- Investor Presentation 2025-26 · Investor Communications
- As per Regulation 24(A) Annual Compliance Report for the year ending 31st March, 2026. · Compliance
- Newspaper advertisements for the quarter ended 31st March, 2026. · Compliance
- Outcome of board meeting results for the quarter and year ending 31st March, 2026 · Results
- Outcome of Board meeting dated 25th May, 2026: Audited results for the quarter and year ended 31st March, 2026. · Results
- Syschem India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve Prior intimation of Board Meeting .... · Results
- Compliance _Regulation 32 for the quarter ending 31st March, 2026. · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹654 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from SYSCHEM (INDIA) LTD.'s filed financials and exchange disclosures
What does SYSCHEM (INDIA) LTD. do?
SYSCHEM (INDIA) LTD. is a Pharmaceuticals & Biotechnology company listed on BSE.
Is SYSCHEM (INDIA) LTD. profitable?
Yes. Over the trailing twelve months SYSCHEM (INDIA) LTD. reported a net profit of ₹6 Cr on revenue of ₹654 Cr.
Does SYSCHEM (INDIA) LTD. pay a dividend?
Not in the latest reported year — SYSCHEM (INDIA) LTD.'s dividend payout for FY26 was nil.
Is SYSCHEM (INDIA) LTD. debt-free?
Effectively yes. It holds ₹8 Cr more cash than debt. Debt stands at 0.00× equity.
Is SYSCHEM (INDIA) LTD. expensive compared with its peers?
On trailing P/E, SYSCHEM (INDIA) LTD. ranks 40 of 170 in Pharmaceuticals — cheaper than 77% of them, against an industry median of 29.6×. This is a position, not a valuation judgement.
How much does the SYSCHEM (INDIA) LTD. share price move in a day?
On a typical session SYSCHEM (INDIA) LTD. moves 1.52% — that is the median absolute close-to-close move across its last 268 trading days. Announcement days are routinely larger.
Where can I track SYSCHEM (INDIA) LTD.'s announcements?
Every NSE and BSE filing by SYSCHEM (INDIA) LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.